This is a news collection page for Canberra. Check this page for latest news headlines covering major stories, events from Canberra and surrounding ACT. Get breaking news faster than any other ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Catch up on all the biggest pharma news to hit the industry last month, spanning from new acquisitions, insights on the NHS ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...

La decima giornata di Serie A conclude il suo secondo giorno con le sfide di Bergamo e Torino: Atalanta-Monza e Juventus-Parma. ATALANTA (3-4-2-1): Carnesecchi; Djimsiti, Hien, Kolasinac; Bellanova, ...

Independent Online, popularly known as IOL, is one of South Africa’s leading news and information websites bringing millions of readers breaking news and updates on Politics, Current Affairs ...

AutoNation faced a $0.21 per share impact from the CDK outage in July, contributing to a 9% decline in gross profit year over year. AutoNation, Inc. AN shares are trading lower after the company ...

The Cloud Development Kit (CDK) is an open source framework, developed by AWS, that allows developers to define cloud application infrastructure as code using programming languages such as Python, ...

Cybersecurity researchers have disclosed a security flaw impacting Amazon Web Services (AWS) Cloud Development Kit (CDK) that could have resulted in an account takeover under specific circumstances.

UCB will ad­vance its an­ti-tau an­ti­body for Alzheimer’s dis­ease so­lo af­ter Roche and Genen­tech walked away from the as­set known as bepranemab.

UCB granted Roche and its biotech unit Genentech an exclusive worldwide license to bepranemab, then called UCB0107, in 2020 as part of a deal worth around $2 billion in milestones. The agreement ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from the open-label, single-arm Phase IV ELEVATUM study ...